OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Factors That Govern the Induction of Long-Lived Antibody Responses
Bryce Chackerian, David S. Peabody
Viruses (2020) Vol. 12, Iss. 1, pp. 74-74
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle
Philip J. M. Brouwer, Aleksandar Antanasijevic, Zachary T. Berndsen, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 185

Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases
Emina Karahmet Sher, Adnan Ćosović, Amina Džidić-Krivić, et al.
Life Sciences (2023) Vol. 319, pp. 121531-121531
Open Access | Times Cited: 44

Recent Advances in the Use of Plant Virus-Like Particles as Vaccines
Ina Baļķe, Andris Zeltiņš
Viruses (2020) Vol. 12, Iss. 3, pp. 270-270
Open Access | Times Cited: 56

An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein
Lucie Jelínková, Hugo Jhun, Allison Eaton, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 44

A virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in non-human primates
Alexandra Fowler, Koen K. A. Van Rompay, Maureen Sampson, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 21

A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques
Ariane Volkmann, Gerrit Koopman, Petra Mooij, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24

The Chimeric Binjari-Zika Vaccine Provides Long-Term Protection against ZIKA Virus Challenge
Jessamine E. Hazlewood, Tang Bing, Kexin Yan, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 85-85
Open Access | Times Cited: 21

Ara h 2–expressing cucumber mosaic virus–like particle (VLP Peanut) induces in vitro tolerogenic cellular responses in peanut-allergic individuals
Janice A. Layhadi, Sviatlana Starchenka, Pieter‐Jan de Kam, et al.
Journal of Allergy and Clinical Immunology (2025) Vol. 155, Iss. 1, pp. 153-165
Closed Access

Regulated microbe vaccines: from concept to (pre-clinical) reduction to practice
Richard Voellmy, David C. Bloom, Nuria Vilaboa
Expert Review of Vaccines (2025)
Open Access

Virus-like particle-based vaccines targeting the Anopheles mosquito salivary protein TRIO
Alexandra Francian, Yevel Flores-García, John R. Powell, et al.
mSphere (2025)
Open Access

Development of Methods to Produce SARS CoV‐2 Virus‐Like Particles at Scale
Melissa A. Edeling, Linda Earnest, Julio Carrera Montoya, et al.
Biotechnology and Bioengineering (2025)
Open Access

In-depth immunochemical characterization of the serum antibody response using a dual-titration microspot assay
Ágnes Melinda Kovács, Zoltán Hérincs, Krisztián Papp, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer
Pola Olczak, Ken Matsui, Margaret Wong, et al.
Journal of Virology (2022) Vol. 96, Iss. 13
Open Access | Times Cited: 16

Advantages and Prospects of Tag/Catcher Mediated Antigen Display on Capsid-Like Particle-Based Vaccines
Kara-Lee Aves, Louise Goksøyr, Adam F. Sander
Viruses (2020) Vol. 12, Iss. 2, pp. 185-185
Open Access | Times Cited: 24

Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines
Hunter McFall-Boegeman, Xuefei Huang
Expert Review of Vaccines (2022) Vol. 21, Iss. 4, pp. 453-469
Open Access | Times Cited: 15

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development
Melinda Ahmels, Filipe Colaço Mariz, Ilona Braspenning‐Wesch, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14

A vaccine targeting the L9 epitope of the malaria circumsporozoite protein confers protection from blood-stage infection in a mouse challenge model
Lucie Jelínková, Yevel Flores-García, Sarah Shapiro, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 13

Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection
Hae‐Ji Kang, Ki‐Back Chu, Keon-Woong Yoon, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 429-429
Open Access | Times Cited: 10

Immunogenicity of Multi-Target Chimeric RHDV Virus-Like Particles Delivering Foreign B-Cell Epitopes
María Zamora-Ceballos, Noelia Moreno, David Gil‐Cantero, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 229-229
Open Access | Times Cited: 8

A Virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in Non-Human Primates
Alexandra Fowler, Koen K. A. Van Rompay, Maureen Sampson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4

Virus-like particle vaccine displaying an external, membrane adjacent MUC16 epitope elicits ovarian cancer-reactive antibodies
Hsin-Fang Tu, Margaret Wong, Ssu-Hsueh Tseng, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1

Longitudinal study of the immune response and memory following natural bovine respiratory syncytial virus infections in cattle of different age
Sara Hägglund, Katarina Näslund, Anna Svensson, et al.
PLoS ONE (2022) Vol. 17, Iss. 9, pp. e0274332-e0274332
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top